{"id":"W3200915536","doi":"10.1016/j.kint.2021.09.005","title":"A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function","year":2021,"lang":"en","type":"article","venue":"Kidney International","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Janssen Pharmaceuticals; Novo Nordisk Fonden; Relypsa; Cytokinetics; Astellas Pharma; Satellite Healthcare; University of Glasgow; Bristol-Myers Squibb; Akebia Therapeutics; Steno Diabetes Center Copenhagen; Novo Nordisk; ReCor Medical; Eli Lilly and Company; AstraZeneca; CSL Behring; Alnylam Pharmaceuticals; Gilead Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; GlaxoSmithKline; Defense Acquisition Program Administration; Amgen; Angion; Pfizer","keywords":"Kidney disease; Dapagliflozin; Medicine; Renal function; Incidence (geometry); Adverse effect; Randomized controlled trial; Internal medicine; Intensive care medicine; Acute kidney injury; Endocrinology; Diabetes mellitus; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000875433,0.0001514474,0.001001962,0.0004373074,0.00001842042,0.000007177523,0.0001440704,0.00004721039,0.0004971621],"category_scores_gemma":[0.006558301,0.00008565123,0.0006179289,0.0004932454,0.0001285716,0.00008489854,0.00008780624,0.00009720062,9.167751e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001488422,"about_ca_system_score_gemma":0.0005660921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000970068,"about_ca_topic_score_gemma":0.0001566659,"domain_scores_codex":[0.9978802,0.0003385494,0.0008963564,0.0002379765,0.0005354933,0.0001114592],"domain_scores_gemma":[0.9982983,0.0005610272,0.0005178264,0.0003101391,0.0001841972,0.0001284754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8375604,0.001906816,0.1382965,0.0001792552,0.009613497,0.00001242443,0.0004002011,0.000549985,0.001436139,0.008422744,0.001051408,0.0005707021],"study_design_scores_gemma":[0.7213883,0.0001950729,0.2610467,0.0007810092,0.004372647,1.905273e-7,0.00008457049,0.01015211,0.0006939273,0.0008491491,0.0003520308,0.00008433356],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883096,0.0001085027,0.0001634885,0.007037423,0.0005054944,0.002616804,0.00008941808,0.000007099427,0.001162188],"genre_scores_gemma":[0.9961723,0.0001468008,0.00005310977,0.0008334346,0.00005175806,0.0003114826,0.0001870934,0.000007474731,0.002236537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1227502,"threshold_uncertainty_score":0.7851373,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01539465636533565,"score_gpt":0.2914013133539956,"score_spread":0.2760066569886599,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}